Your browser doesn't support javascript.
A risk scoring system to predict progression to severe pneumonia in patients with Covid-19.
Lee, Ji Yeon; Nam, Byung-Ho; Kim, Mhinjine; Hwang, Jongmin; Kim, Jin Young; Hyun, Miri; Kim, Hyun Ah; Cho, Chi-Heum.
  • Lee JY; Department of Infectious Diseases, Keimyung University Dongsan Hospital, Keimyung University School of Medicine, Daegu, Republic of Korea.
  • Nam BH; Covid-19 Task Force Team of Keimyung University Daegu Dongsan Hospital, Daegu, Republic of Korea.
  • Kim M; HERINGS, Institute of Advanced Clinical and Biomedical Research, Seoul, Republic of Korea.
  • Hwang J; Covid-19 Task Force Team of Keimyung University Daegu Dongsan Hospital, Daegu, Republic of Korea.
  • Kim JY; Division of Health Policy and Administration, School of Public Health, University of Illinois at Chicago, Chicago, USA.
  • Hyun M; Department of Cardiology, Keimyung University Dongsan Hospital, Keimyung University School of Medicine, Daegu, Republic of Korea.
  • Kim HA; Department of Radiology, Keimyung University Dongsan Hospital, Keimyung University School of Medicine, Daegu, Republic of Korea.
  • Cho CH; Department of Infectious Diseases, Keimyung University Dongsan Hospital, Keimyung University School of Medicine, Daegu, Republic of Korea.
Sci Rep ; 12(1): 5390, 2022 03 30.
Article in English | MEDLINE | ID: covidwho-1768842
ABSTRACT
Rapid outbreak of coronavirus disease 2019 (Covid-19) raised major concern regarding medical resource constraints. We constructed and validated a scoring system for early prediction of progression to severe pneumonia in patients with Covid-19. A total of 561 patients from a Covid-19 designated hospital in Daegu, South Korea were randomly divided into two cohorts development cohort (N = 421) and validation cohort (N = 140). We used multivariate logistic regression to identify four independent risk predictors for progression to severe pneumonia and constructed a risk scoring system by giving each factor a number of scores corresponding to its regression coefficient. We calculated risk scores for each patient and defined two groups low risk (0 to 8 points) and high risk (9 to 20 points). In the development cohort, the sensitivity and specificity were 83.8% and 78.9%. In the validation cohort, the sensitivity and specificity were 70.8% and 79.3%, respectively. The C-statistics was 0.884 (95% CI 0.833-0.934) in the development cohort and 0.828 (95% CI 0.733-0.923) in the validation cohort. This risk scoring system is useful to identify high-risk group for progression to severe pneumonia in Covid-19 patients and can prevent unnecessary overuse of medical care in limited-resource settings.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia / COVID-19 Type of study: Cohort study / Diagnostic study / Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Limits: Humans Language: English Journal: Sci Rep Year: 2022 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia / COVID-19 Type of study: Cohort study / Diagnostic study / Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Limits: Humans Language: English Journal: Sci Rep Year: 2022 Document Type: Article